Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. [Phase 1]
Phase I study of alemtuzumab in relapsed ovarian cancer and primary peritoneal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer
This document reports the completion of a clinical trial evaluating laparoscopy for primary cytoreductive surgery in advanced ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]
Phase 2 trial of regorafenib in recurrent ovarian, primary peritoneal, and fallopian tube cancer was terminated with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma [Phase 1, Phase 2]
A phase 1/2 trial evaluating the combination of lenalidomide with topotecan in advanced ovarian cancer and primary peritoneal cancer has com…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating DCVAC/OvCa plus standard of care in relapsed platinum-resistant ovarian cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Taxol Carboplatin and Erythropoetin [Phase 2]
Phase 2 trial evaluating paclitaxel (Taxol) with carboplatin and erythropoietin for ovarian cancer; results from the completed study have be…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE) [Phase 3]
Phase 3 trial of pertuzumab in platinum-resistant, HER3 mRNA–positive epithelial ovarian cancer (PENELOPE) has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Bevacizumab and Carboplatin for Patients With Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab in combination with carboplatin for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1/Phase 2 studies of veliparib as monotherapy in relapsed BRCA-mutated ovarian ca…
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer [Phase 1]
A completed Phase 1 study evaluating liposomal doxorubicin (DOXIL/CAELYX) in patients with advanced or refractory solid malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors [NA]
This document provides an update on the efficacy of the Pelvic Autonomic Nerve Monitoring System (PAMS I) in female patients with pelvic tum…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of DMUC5754A administered intravenously in patients with platinum-resistant ovarian…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian Cancer [Phase 1]
This clinical trial update reports a Phase 1 dose-finding study of RO5323441 in patients with metastatic, treatment-refractory colorectal or…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Patient Reported Symptoms in Ovarian Cancer (PRECISION)
This clinical trial update reports on patient-reported symptoms in the PRECISION study for ovarian cancer. The trial is sponsored by Genente…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment [Phase 4]
Phase 4 trial evaluating a slowed carboplatin infusion during re-treatment for ovarian cancer was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer [NA]
A completed clinical trial evaluating whether a low-fiber or high-fiber diet reduces bowel-related side effects in patients undergoing radia…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Accelerating Gastrointestinal Recovery [Phase 3]
Phase 3 trial completed evaluating acceleration of gastrointestinal recovery in patients with ovarian cancer, fallopian tube cancer, and per…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011) [Phase 1]
This Phase 1 trial (MK-4827-011) evaluated niraparib in combination with pegylated liposomal doxorubicin in participants with advanced solid…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers [Phase 1]
This entry covers a Phase 1 safety study of a human MUC-1 adenoviral vector vaccine designed for immunotherapy of epithelial cancers. The st…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Ovarian Cancer and Immune Response to Flu Vaccine
A completed clinical trial evaluating the immune response to an influenza vaccine in patients with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating an NY-ESO-1 vaccine therapy with or without sirolimus in patients whose tumors express NY-ESO-1.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of vorinostat with carboplatin and gemcitabine in women with recurrent, platinum-sensitive ovarian cancer; study te…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy [Phase 1]
Phase 1 safety study of 212Pb-TCMC-Trastuzumab radioimmunotherapy has completed, evaluating safety in multiple HER2-expressing cancers. The …
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers [Phase 1]
Phase 1, single-dose pilot study evaluating radiolabeled amatuximab (MORAb-009) in mesothelin-overexpressing cancers has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1]
This Phase 1 trial evaluated veliparib as a single agent or in combination with chemotherapy in adults with solid tumors and has completed, …